SMTL ID : 5unp.1 (1 other biounit)

Structure of CDC2-Like Kinase 2 (CLK2) in Complex with Compound T-025 [N2-methyl-N4-(pyrimidin-2-ylmethyl)-5-(quinolin-6-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine]

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.92 Å

Oligo State

monomer

Ligands

1 x 8FY: N~2~-methyl-N~4~-[(pyrimidin-2-yl)methyl]-5-(quinolin-6-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine(Non-covalent)

8FY.1: 16 residues within 4Å: Chain A: L.42, G.43, E.44, F.47, V.50, A.64, K.66, V.100, F.116, E.117, L.119, G.120, N.168, L.170, V.199, D.200 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:K.66, A:L.170, A:V.199 Hydrogen bonds: A:E.117, A:L.119, A:L.119 pi-Stacking: A:F.116

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Iwai, K. et al., A novel CLK inhibitor exhibits anti-tumor efficacies via modulating pre-mRNA splicing and targeting a MYC-dependent vulnerability. Embo Mol Med (2018)

Release Date

2018-05-09

Peptides

Dual specificity protein kinase CLK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase CLK2

Related Entries With Identical Sequence